$GHDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOMIC HEALTH INC. Get notifications about new insider transactions in GENOMIC HEALTH INC for free.
Page: < prev 1 ... 16 17 18 19 20 21 22 23 24 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 26 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 27.93 | 5,000 | 139,630 | 372,849 | 377.8 K to 372.8 K (-1.32 %) |
Apr 24 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 27.79 | 5,000 | 138,964 | 250,656 | 255.7 K to 250.7 K (-1.96 %) |
Apr 17 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 27.98 | 1,000 | 27,980 | 18,355 | 19.4 K to 18.4 K (-5.17 %) |
Apr 12 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 28.38 | 10,000 | 283,790 | 1,275,117 | 1.3 M to 1.3 M (-0.78 %) |
Apr 12 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 29.48 | 831 | 24,497 | 1,285,117 | 1.3 M to 1.3 M (-0.06 %) |
Apr 12 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 28.75 | 9,169 | 263,584 | 1,285,948 | 1.3 M to 1.3 M (-0.71 %) |
Apr 06 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 47,868 | |
Apr 06 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 30.28 | 2,500 | 75,691 | 13,507 | 16 K to 13.5 K (-15.62 %) |
Apr 06 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 16,007 | 13.5 K to 16 K (+18.51 %) |
Apr 03 2012 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Grant | A | 30.61 | 326 | 9,979 | 1,937 | 1.6 K to 1.9 K (+20.24 %) |
Apr 03 2012 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 30.61 | 326 | 9,979 | 1,937 | 1.6 K to 1.9 K (+20.24 %) |
Apr 03 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Grant | A | 30.61 | 326 | 9,979 | 1,937 | 1.6 K to 1.9 K (+20.24 %) |
Apr 03 2012 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 30.61 | 326 | 9,979 | 50,753 | 50.4 K to 50.8 K (+0.65 %) |
Mar 26 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 30.07 | 5,000 | 150,337 | 255,656 | 260.7 K to 255.7 K (-1.92 %) |
Mar 23 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 30.08 | 5,000 | 150,415 | 377,849 | 382.8 K to 377.8 K (-1.31 %) |
Mar 26 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 30.08 | 5,000 | 150,415 | 377,849 | 382.8 K to 377.8 K (-1.31 %) |
Mar 26 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 30.08 | 5,000 | 150,415 | 377,849 | 382.8 K to 377.8 K (-1.31 %) |
Mar 19 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 31.08 | 1,000 | 31,080 | 19,355 | 20.4 K to 19.4 K (-4.91 %) |
Mar 23 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 30.07 | 5,000 | 150,337 | 255,656 | 260.7 K to 255.7 K (-1.92 %) |
Mar 14 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 31.12 | 15,000 | 466,764 | 1,295,117 | 1.3 M to 1.3 M (-1.14 %) |
Mar 14 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 30.98 | 15,000 | 464,681 | 1,310,117 | 1.3 M to 1.3 M (-1.13 %) |
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 30.36 | 516 | 15,668 | 227,840 | 227.3 K to 227.8 K (+0.23 %) |
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.88 | 583 | 17,420 | 227,324 | 226.7 K to 227.3 K (+0.26 %) |
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 50,368 | |
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 29.94 | 2,500 | 74,850 | 13,507 | 16 K to 13.5 K (-15.62 %) |
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 16,007 | 13.5 K to 16 K (+18.51 %) |
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 30.36 | 2,162 | 65,647 | 1,484,977 | 1.5 M to 1.5 M (+0.15 %) |
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.88 | 2,346 | 70,097 | 1,482,815 | 1.5 M to 1.5 M (+0.16 %) |
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 30.36 | 19,513 | 592,489 | 8,255,421 | 8.2 M to 8.3 M (+0.24 %) |
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.88 | 22,071 | 659,464 | 8,235,908 | 8.2 M to 8.2 M (+0.27 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 30.07 | 69,783 | 2,098,291 | 8,213,837 | 8.1 M to 8.2 M (+0.86 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.96 | 85,231 | 2,553,188 | 8,144,054 | 8.1 M to 8.1 M (+1.06 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.52 | 91,459 | 2,699,915 | 8,058,823 | 8 M to 8.1 M (+1.15 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.47 | 15,288 | 450,543 | 7,967,364 | 8 M to 8 M (+0.19 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 30.07 | 1,845 | 55,477 | 226,741 | 224.9 K to 226.7 K (+0.82 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.96 | 2,254 | 67,521 | 224,896 | 222.6 K to 224.9 K (+1.01 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.52 | 2,419 | 71,410 | 222,642 | 220.2 K to 222.6 K (+1.10 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.47 | 405 | 11,936 | 220,223 | 219.8 K to 220.2 K (+0.18 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 30.07 | 8,372 | 251,736 | 1,480,469 | 1.5 M to 1.5 M (+0.57 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.96 | 10,225 | 306,301 | 1,472,097 | 1.5 M to 1.5 M (+0.70 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.52 | 10,972 | 323,899 | 1,461,872 | 1.5 M to 1.5 M (+0.76 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.47 | 1,763 | 51,956 | 1,450,900 | 1.4 M to 1.5 M (+0.12 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.06 | 4,149 | 120,562 | 219,818 | 215.7 K to 219.8 K (+1.92 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.11 | 1,353 | 39,384 | 215,669 | 214.3 K to 215.7 K (+0.63 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.03 | 974 | 28,276 | 214,316 | 213.3 K to 214.3 K (+0.46 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.06 | 156,902 | 4,559,274 | 7,952,076 | 7.8 M to 8 M (+2.01 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.11 | 51,248 | 1,491,752 | 7,795,174 | 7.7 M to 7.8 M (+0.66 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.03 | 36,881 | 1,070,678 | 7,743,926 | 7.7 M to 7.7 M (+0.48 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.06 | 19,552 | 568,144 | 1,449,137 | 1.4 M to 1.4 M (+1.37 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.11 | 5,934 | 172,730 | 1,429,585 | 1.4 M to 1.4 M (+0.42 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.03 | 4,270 | 123,961 | 1,423,651 | 1.4 M to 1.4 M (+0.30 %) |
Feb 27 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 28.85 | 5,000 | 144,255 | 260,656 | 265.7 K to 260.7 K (-1.88 %) |
Feb 27 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 28.15 | 5,000 | 140,740 | 265,656 | 270.7 K to 265.7 K (-1.85 %) |
Feb 27 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 28.14 | 5,000 | 140,724 | 382,849 | 387.8 K to 382.8 K (-1.29 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.12 | 1,639 | 46,095 | 213,342 | 211.7 K to 213.3 K (+0.77 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.98 | 145 | 4,057 | 211,703 | 211.6 K to 211.7 K (+0.07 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.98 | 1,238 | 34,635 | 211,558 | 210.3 K to 211.6 K (+0.59 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.12 | 62,098 | 1,746,432 | 7,707,045 | 7.6 M to 7.7 M (+0.81 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.98 | 5,511 | 154,204 | 7,644,947 | 7.6 M to 7.6 M (+0.07 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.98 | 46,909 | 1,312,368 | 7,639,436 | 7.6 M to 7.6 M (+0.62 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.12 | 7,477 | 210,282 | 1,419,381 | 1.4 M to 1.4 M (+0.53 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.98 | 638 | 17,852 | 1,411,904 | 1.4 M to 1.4 M (+0.05 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.98 | 5,217 | 145,955 | 1,411,266 | 1.4 M to 1.4 M (+0.37 %) |
Feb 17 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Payment of Exercise | F | 28.97 | 629 | 18,222 | 387,849 | 388.5 K to 387.8 K (-0.16 %) |
Feb 17 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Payment of Exercise | F | 28.97 | 629 | 18,222 | 1,325,117 | 1.3 M to 1.3 M (-0.05 %) |
Feb 17 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Payment of Exercise | F | 28.97 | 545 | 15,789 | 20,600 | 21.1 K to 20.6 K (-2.58 %) |
Feb 17 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 28.76 | 755 | 21,714 | 21,145 | 21.9 K to 21.1 K (-3.45 %) |
Feb 17 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 936 | 0 | 270,656 | 271.6 K to 270.7 K (-0.34 %) |
Feb 17 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 936 | 0 | 14,770 | 13.8 K to 14.8 K (+6.77 %) |
Feb 17 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Payment of Exercise | F | 28.97 | 1,396 | 40,442 | 18,604 | 20 K to 18.6 K (-6.98 %) |
Feb 17 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Payment of Exercise | F | 28.97 | 943 | 27,319 | 13,507 | 14.5 K to 13.5 K (-6.53 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.85 | 10,838 | 323,566 | 1,406,049 | 1.4 M to 1.4 M (+0.78 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.61 | 11,021 | 326,338 | 1,395,211 | 1.4 M to 1.4 M (+0.80 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.96 | 41 | 1,187 | 1,384,190 | 1.4 M to 1.4 M (0.00 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.88 | 3,944 | 113,892 | 1,384,149 | 1.4 M to 1.4 M (+0.29 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.44 | 7,341 | 208,756 | 1,380,205 | 1.4 M to 1.4 M (+0.53 %) |
Feb 17 2012 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Payment of Exercise | F | 28.97 | 629 | 18,222 | 132,846 | 133.5 K to 132.8 K (-0.47 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.85 | 2,419 | 72,219 | 210,320 | 207.9 K to 210.3 K (+1.16 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.61 | 2,460 | 72,842 | 207,901 | 205.4 K to 207.9 K (+1.20 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.96 | 10 | 290 | 205,441 | 205.4 K to 205.4 K (0.00 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.88 | 849 | 24,517 | 205,431 | 204.6 K to 205.4 K (+0.41 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.44 | 1,475 | 41,945 | 204,582 | 203.1 K to 204.6 K (+0.73 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.85 | 91,543 | 2,732,998 | 7,592,527 | 7.5 M to 7.6 M (+1.22 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.61 | 93,088 | 2,756,392 | 7,500,984 | 7.4 M to 7.5 M (+1.26 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.96 | 349 | 10,108 | 7,407,896 | 7.4 M to 7.4 M (0.00 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.88 | 32,125 | 927,680 | 7,407,547 | 7.4 M to 7.4 M (+0.44 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.44 | 55,804 | 1,586,898 | 7,375,422 | 7.3 M to 7.4 M (+0.76 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.52 | 28,469 | 754,895 | 7,319,618 | 7.3 M to 7.3 M (+0.39 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.62 | 18,628 | 495,913 | 7,291,149 | 7.3 M to 7.3 M (+0.26 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.60 | 112,735 | 2,999,123 | 7,272,521 | 7.2 M to 7.3 M (+1.57 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.24 | 3,883 | 101,874 | 7,159,786 | 7.2 M to 7.2 M (+0.05 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.33 | 49,670 | 1,307,632 | 7,155,903 | 7.1 M to 7.2 M (+0.70 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.27 | 2,441 | 64,122 | 7,106,233 | 7.1 M to 7.1 M (+0.03 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.26 | 60,315 | 1,583,594 | 7,103,792 | 7 M to 7.1 M (+0.86 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.18 | 135,681 | 3,551,545 | 7,043,477 | 6.9 M to 7 M (+1.96 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.17 | 6,093 | 159,424 | 6,907,796 | 6.9 M to 6.9 M (+0.09 %) |
Feb 13 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 26.25 | 10,000 | 262,495 | 1,325,746 | 1.3 M to 1.3 M (-0.75 %) |
Feb 13 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 26.10 | 10,000 | 261,029 | 1,335,746 | 1.3 M to 1.3 M (-0.74 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.52 | 753 | 19,967 | 203,107 | 202.4 K to 203.1 K (+0.37 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.62 | 492 | 13,098 | 202,354 | 201.9 K to 202.4 K (+0.24 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.60 | 2,980 | 79,278 | 201,862 | 198.9 K to 201.9 K (+1.50 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.24 | 102 | 2,676 | 198,882 | 198.8 K to 198.9 K (+0.05 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.33 | 1,312 | 34,540 | 198,780 | 197.5 K to 198.8 K (+0.66 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.27 | 64 | 1,681 | 197,468 | 197.4 K to 197.5 K (+0.03 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.26 | 1,594 | 41,851 | 197,404 | 195.8 K to 197.4 K (+0.81 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.18 | 3,585 | 93,840 | 195,810 | 192.2 K to 195.8 K (+1.87 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.17 | 161 | 4,213 | 192,225 | 192.1 K to 192.2 K (+0.08 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.52 | 4,378 | 116,089 | 1,372,864 | 1.4 M to 1.4 M (+0.32 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.62 | 2,865 | 76,272 | 1,368,486 | 1.4 M to 1.4 M (+0.21 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.60 | 17,339 | 461,275 | 1,365,621 | 1.3 M to 1.4 M (+1.29 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.24 | 615 | 16,135 | 1,348,282 | 1.3 M to 1.3 M (+0.05 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.33 | 7,858 | 206,873 | 1,347,667 | 1.3 M to 1.3 M (+0.59 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.27 | 387 | 10,166 | 1,339,809 | 1.3 M to 1.3 M (+0.03 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.26 | 9,891 | 259,692 | 1,339,422 | 1.3 M to 1.3 M (+0.74 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.18 | 22,251 | 582,436 | 1,329,531 | 1.3 M to 1.3 M (+1.70 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.17 | 999 | 26,139 | 1,307,280 | 1.3 M to 1.3 M (+0.08 %) |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | A | 29.34 | 60,000 | 1,760,400 | 60,000 | |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Grant | A | 0.00 | 6,700 | 0 | 14,450 | 7.8 K to 14.5 K (+86.45 %) |
Feb 09 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 52,868 | |
Feb 09 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 26.47 | 2,500 | 66,172 | 14,450 | 17 K to 14.5 K (-14.75 %) |
Feb 09 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 16,950 | 14.5 K to 17 K (+17.30 %) |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | A | 29.34 | 36,000 | 1,056,240 | 36,000 | |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Grant | A | 0.00 | 4,000 | 0 | 21,900 | 17.9 K to 21.9 K (+22.35 %) |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | A | 29.34 | 50,000 | 1,467,000 | 50,000 | |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Grant | A | 0.00 | 5,700 | 0 | 388,478 | 382.8 K to 388.5 K (+1.49 %) |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | A | 29.34 | 90,000 | 2,640,600 | 90,000 | |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Option Exercise | A | 29.34 | 18,000 | 528,120 | 18,000 | |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Baker Joffre | Chief Scientific Of ... | Grant | A | 0.00 | 2,000 | 0 | 133,475 | 131.5 K to 133.5 K (+1.52 %) |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Option Exercise | A | 29.34 | 40,000 | 1,173,600 | 40,000 | |
Feb 07 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Grant | A | 0.00 | 4,600 | 0 | 1,345,746 | 1.3 M to 1.3 M (+0.34 %) |
Jan 27 2012 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Option Exercise | M | 1.33 | 2,000 | 2,653 | 9,346 | |
Jan 27 2012 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Sell | S | 27.51 | 2,000 | 55,020 | 6,149 | 8.1 K to 6.1 K (-24.54 %) |
Jan 27 2012 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Buy | M | 1.33 | 2,000 | 2,653 | 8,149 | 6.1 K to 8.1 K (+32.53 %) |
Jan 26 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 26.42 | 5,000 | 132,085 | 273,292 | 278.3 K to 273.3 K (-1.80 %) |
Jan 25 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 26.62 | 5,000 | 133,079 | 278,292 | 283.3 K to 278.3 K (-1.76 %) |
Jan 25 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 26.74 | 5,000 | 133,678 | 382,778 | 387.8 K to 382.8 K (-1.29 %) |
Jan 18 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 28.00 | 1,000 | 27,999 | 17,900 | 18.9 K to 17.9 K (-5.29 %) |
Jan 18 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 55,368 | |
Jan 18 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 27.54 | 2,500 | 68,844 | 7,750 | 10.3 K to 7.8 K (-24.39 %) |
Jan 18 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 10,250 | 7.8 K to 10.3 K (+32.26 %) |
Jan 12 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 28.23 | 100 | 2,823 | 1,341,146 | 1.3 M to 1.3 M (-0.01 %) |
Jan 12 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 27.55 | 9,900 | 272,789 | 1,341,246 | 1.4 M to 1.3 M (-0.73 %) |
Jan 12 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 27.35 | 10,000 | 273,530 | 1,351,146 | 1.4 M to 1.4 M (-0.73 %) |
Jan 06 2012 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 25.39 | 393 | 9,978 | 50,427 | 50 K to 50.4 K (+0.79 %) |
Jan 06 2012 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 25.39 | 393 | 9,978 | 1,611 | 1.2 K to 1.6 K (+32.27 %) |
Jan 06 2012 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Grant | A | 25.39 | 393 | 9,978 | 1,611 | 1.2 K to 1.6 K (+32.27 %) |
Jan 06 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Grant | A | 25.39 | 393 | 9,978 | 1,611 | 1.2 K to 1.6 K (+32.27 %) |
Dec 23 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 26.03 | 5,000 | 130,156 | 387,778 | 392.8 K to 387.8 K (-1.27 %) |
Dec 08 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 57,868 |